The Cardiovascular Imaging Research Program focuses on developing and using noninvasive imaging methods that allow the early detection, prevention, and treatment of cardiovascular disease.
The goal of the cardiovascular imaging program is to develop new non-invasive imaging techniques for the diagnosis and treatment of cardiovascular disease. The primary focus of our research is atherosclerosis, a disease that is very expensive to treat. As the primary cause of heart attacks and strokes, we have worked with a variety of pharmaceutical companies to run multicenter clinical trials in our lab.
At Mount Sinai, we develop new power sequences that focus on developing new techniques for cardiovascular imaging. We are developing and applying new imaging approaches that allow the assessment not only of the structure of blood vessels, but also of the composition of the vessel walls—enabling atherosclerosis-associated abnormalities in the arteries (including the coronary arteries) to be observed down to the cellular and molecular level. We have also studied the permeability and inflammation in the arterial and vessel walls.
With state-of-the art research facilities, we are equipped with equipment including a whole body scanner to a fully integrated MRI/PET scanner, as well as a new CT scanner. This state-of-the-art equipment has allowed for higher resolution images than ever before.
Research Study Volunteers Needed
Are you interested to participate in any of the imaging research studies?
Find out more about our Cardiovascular studies.
Mount Sinai Hospital opens one of the first centers to study and treat people with what being called “Post-acute COVID Syndrome.”
Please click on the image to watch the 60 Minutes segment. New York, NY (November 22, 2020) — COVID-19 was initially thought to be a disease that was serious for the eldery and people with preexisting conditions. A potentially tough, but temporary respiratory illness...
Nanobiologic immunotherapy uses tiny, bioengineered material to harness immune systemNew York, NY (October 29, 2020) — A groundbreaking new type of cancer immunotherapy developed at the Icahn School of Medicine at Mount Sinai trains the innate immune system to help it...
Led by Robert Hirten, MD and Zahi Fayad, PhD, the study draws upon the collaborative efforts of the Mount Sinai COVID Informatics Center (MSCIC) and is open to all employees in the health system. It uses a unique phone App to administer questions and collect data from...
Artificial intelligence–enabled rapid diagnosis of patients with COVID-19
Xueyan Mei, Hao-Chih Lee, […] Yang Yang
Nat Med (2020).
Probing myeloid cell dynamics in ischaemic heart disease by nanotracer hot-spot imaging
Max L. Senders, Anu E. Meerwaldt, ... Willem J. M. Mulder
Nat. Nanotechnol. 15, 398–405 (2020).